Policy & GovernmentEvidence Reviews
Loneliness Interventions: How Much Do They Actually Move the Needle
A review of effect sizes, not p-values, across the loneliness intervention literature: what social prescribing, befriending, and structured behavioural programmes actually deliver, and how those numbers compare to the mortality risk they are meant to offset.
Center for Social Connection

A policy brief that reports an intervention “significantly reduced loneliness” has told the reader almost nothing. Statistical significance is a function of sample size as much as of effect. What matters for deciding whether to fund a programme is the size of the change, in units a clinician or a commissioner can compare against something else. That comparison is largely missing from the loneliness literature, and where it is present, it is not flattering to the most widely funded intervention.
The baseline the interventions are meant to beat
Julianne Holt-Lunstad’s 2015 meta-analysis in Perspectives on Psychological Science put the mortality odds ratio for social isolation at 1.29, for loneliness at 1.26, and for living alone at 1.32. The American Heart Association’s 2022 scientific statement found isolation and loneliness associated with roughly a 30% increased risk of heart attack, stroke, or death from either. The 2023 U.S. Surgeon General’s advisory compared the mortality risk of disconnection to smoking up to 15 cigarettes a day. These are the numbers that justify treating loneliness as a health problem rather than a mood. They are also, notably, association measures from observational cohorts, not effect sizes from trials of a fix. An intervention effect size and an epidemiological risk ratio are not the same currency, but the gap between the two is where the honest assessment of “what works” has to sit.
Social prescribing: real, but underspecified
Social prescribing — routing patients toward community groups, arts programmes, or volunteering instead of, or alongside, medical treatment — is now the default UK policy response, embedded since the 2018 national loneliness strategy. Two systematic reviews from 2021 both found positive effects: one, in Perspectives in Public Health, found all nine included studies reported positive individual impacts, with three showing reduced use of GP, emergency, or inpatient services. The other, in the International Journal of Environmental Research and Public Health, reported increases in self-esteem and confidence as the headline outcome.
Neither review reports a pooled effect size in a standardised unit like a UCLA Loneliness Scale point change. A 2022 qualitative meta-synthesis in BMC Health Services Research found that participants describe benefit extending beyond social contact into restored purpose and participation — a plausible mechanism, but a qualitative one, incapable of telling a funder how many points of loneliness reduction a given programme buys per pound spent. A 2025 systematic review protocol on medRxiv makes the gap explicit: despite growing adoption, the effectiveness of social prescribing for older adults remains unclear, and only one peer-reviewed randomised controlled trial exists in the area. A policy that is well-established administratively is still, on the evidence, poorly quantified.
Where actual numbers exist, the picture gets more interesting
Three recent randomised trials do report effect sizes in comparable units, and the pattern across them is worth taking seriously.
A 2025 trial in Clinical Gerontologist tested befriending — regular, informal one-to-one contact — against a control in residential aged care. It reduced UCLA Loneliness Scale scores by 2.39 points at 8 weeks and 2.71 points at 16 weeks. That is a real, durable effect, and befriending is cheap and scalable relative to clinical intervention.
But the 2024 HEAL-HOA trial in The Lancet Healthy Longevity, testing volunteering and prosocial engagement against a control among lonely older adults in Hong Kong, and its 2026 successor testing behavioural activation and mindfulness delivered by telephone, point toward a different tier of effect. The 2026 HEAL-HOA trial enrolled 1,151 older adults who were living in poverty, alone, and digitally excluded, and delivered eight 30-minute telephone sessions over one month, run by trained laypeople who were themselves older adults with lived experience of loneliness. It significantly reduced loneliness at 12 months compared with a befriending control group. The comparison group losing is the finding. Befriending — the intervention most commissioners already fund — was outperformed head-to-head by a structured, brief, manualised psychological approach delivered by peers rather than professionals.
Put the three trials side by side and a hierarchy emerges that the significance-only literature obscures: contact alone helps, at a measurable but modest magnitude; structured psychological content, even delivered briefly and by non-clinicians, appears to help more. That is a testable, falsifiable claim about intervention design, not a vague endorsement of “more social contact.” It has not yet been replicated widely enough to be a settled finding, but it is the kind of comparison the field needs more of, not fewer.
What this means for the size of the ambition
The Surgeon General’s advisory frames disconnection as comparable in mortality risk to heavy smoking. If that comparison is to do real work, the interventions arrayed against it need to be evaluated the way smoking-cessation programmes are: by the size of the reduction in the outcome, at defined time points, against a defined comparator, not by whether a p-value cleared 0.05 in a sample too small to detect anything but a large effect. Most of the loneliness intervention literature is not built that way yet. Programme evaluations dominate; randomised trials with named effect sizes remain rare enough that three of them can be discussed individually in a single article.
A better evidence base would report loneliness-scale point changes at multiple follow-up intervals, compare interventions against active comparators rather than no-treatment controls, and separate isolation outcomes from loneliness outcomes rather than treating a reduction in either as interchangeable evidence of success. Until that becomes standard, the honest summary is narrower than the political rhetoric: something works, the size of the effect is larger for structured psychological content than for contact alone, and most of what is currently funded has not been measured well enough to say by how much.
Sources
- Loneliness and Social Isolation as Risk Factors for Mortality: A Meta-Analytic Review
- Effects of Objective and Perceived Social Isolation on Cardiovascular and Brain Health: A Scientific Statement From the American Heart Association
- Our Epidemic of Loneliness and Isolation: The U.S. Surgeon General Advisory on the Healing Effects of Social Connection and Community
- Can Social Prescribing Foster Individual and Community Well-Being? A Systematic Review of the Evidence
- Understanding Loneliness: A Systematic Review of the Impact of Social Prescribing Initiatives on Loneliness
- Do People Perceive Benefits in the Use of Social Prescribing to Address Loneliness and/or Social Isolation? A Qualitative Meta-Synthesis
- The Role of Social Prescribing in Alleviating Social Isolation and Loneliness in Older Adults: A Systematic Review Protocol
- The Effects of Volunteering on Loneliness Among Lonely Older Adults: The HEAL-HOA Dual Randomised Controlled Trial
- Behavioral Activation and Mindfulness Interventions in Reducing Loneliness and Improving Well-Being in Older Adults: The HEAL-HOA Randomized Clinical Trial
- Randomized Controlled Trial on the Impact of Befriending on Depression, Anxiety, Loneliness, and Social Support in Older People in Aged Care
- A Connected Society: A Strategy for Tackling Loneliness